John A. Murphy III

Washington, United States
John Murphy serves as the Vice President and Deputy General Counsel at the Biotechnology Innovation Organization (BIO). BIO is the largest trade association in the world representing biotechnology companies. BIO members are involved in the research and development of innovative healthcare, agricultural, and environmental biotechnology products, thereby expanding the boundaries of science to benefit humanity by providing better healthcare, enhanced agriculture, and a cleaner and safer environment.

Mr. Murphy’s role encompasses all legal issues impacting healthcare biotechnology across the Country. His responsibilities include issues in Congressional legislation, FDA, CMS and various other federal agency regulatory issues, litigation, and support on state-developed biotechnology laws and regulations. Mr. Murphy is a frequent speaker on issues associated with patient access to prescription medicines, prescription drug abuse, drug pricing, and more general issues impacting medicine approvals and innovation in the United States.

Mr. Murphy is a graduate of Villanova University and the Catholic University Columbus School of Law. He worked on healthcare regulatory and enforcement issues at Hogan Lovells, LLP, and served as Assistant General Counsel for the Pharmaceutical Research and Manufacturers of America before joining BIO.
Speaking In
10:30 AM - 11:55 AM (EST)
Wednesday, February 17

Both U.S. political parties have proposed changes to the reimbursement process for FDA-approved…